Origin (YC Winter 2026)

TL;DR: Origin is a Y Combinator Winter 2026 startup AI and Data for Cancer Therapeutics, currently active with a team of 4.

AI and Data for Cancer Therapeutics

YC ID
31064
YC Batch
Winter 2026
Status
Active
Team size
4
Industry
Healthcare, Drug Discovery and Delivery
YC profile
https://www.ycombinator.com/companies/origin-bio

Last verified:

Creating the largest patient-derived cancer single-cell dataset for licensing to pharmaceutical and AI companies. These datasets are unique as they screen the effects of various drugs and genetic medicines under the control of our DNA switches.

Built by LemStudio

Building or buying SaaS? Try our founder tools →

Frequently asked questions

Is Origin a YC (Y Combinator) company?

Yes. Origin was funded by Y Combinator in the Winter 2026 batch. AI and Data for Cancer Therapeutics

What does Origin do?

Creating the largest patient-derived cancer single-cell dataset for licensing to pharmaceutical and AI companies. These datasets are unique as they screen the effects of various drugs and genetic medicines under the control of our DNA switches.

What YC batch was Origin in?

Origin was part of Y Combinator's Winter 2026 batch.

How big is Origin?

Origin has a team of 4 people according to Y Combinator's directory.

Is Origin still active?

Origin is currently listed as Active with a team of 4 in Y Combinator's directory.

More YC Winter 2026 companies

More Healthcare YC startups

Explore related YC hubs

Loading interactive view…